Home›Articles›A vascular-targeting drug that did not extend survival in mesotheliomaArticleA vascular-targeting drug that did not extend survival in mesotheliomaArticlesConnectionsSourcesComments (0)Reader Challenges (0)ConnectionsArticle OnNGR-hTNF (antitumor recombinant protein), Drugs and Medicinal Substances Well-attested SourcesNGR-hTNF in combination with best investigator choice in previously treated malignant pleural mesothelioma (NGR015)Abstract: InterpretationQuote, Abstract: InterpretationThe study did not meet its primary endpoint.View the SourceMedicine Atlas Original Articlestier 1Comments (0)No comments yet. Be the first to share a thought.Sign in to join the discussion.Reader Challenges (0)No disputes yet. Spotted an error or a better source? Open the first one.Sign in to dispute this or suggest a correction.